Market Capitalization | 115.7M |
Book Value | $0.21 |
Earnings Per Share (EPS) | -0.47 |
Wall Street Target Price | 3.52 |
Profit Margin | -46.23% |
Operating Margin TTM | -63.85% |
Return On Assets TTM | -30.61% |
Return On Equity TTM | -329.78% |
Revenue TTM | 51.6M |
Revenue Per Share TTM | 1.03 |
Quarterly Revenue Growth YOY | 26.8% |
Gross Profit TTM | 14.0M |
EBITDA | -22.5M |
Diluted Eps TTM | -0.47 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.53 |
EPS Estimate Next Year | -0.47 |
EPS Estimate Current Quarter | -0.13 |
EPS Estimate Next Quarter | -0.14 |
Sell
Neutral
Buy
Augmedix Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|
Touchstone Climate Transition Etf
$2.35
+0.0%
Atlas Lithium Corp
$2.35
+0.0%
Flexshares Quality Dividend
$2.35
+0.0%
Blackrock New York Muni Inc
$2.35
+0.0%
Timothy Plan International Etf
$2.35
+0.0%
Alger 35 Etf
$2.35
+0.0%
Aadi Bioscience Inc
$2.35
+0.0%
Goldman Sachs Access Inflati
$2.35
+0.0%
Kolibri Global Energy Inc
$2.35
+0.0%